Distinction

Raphaƫl Margueron, Junior Researcher Grand Prix 2022 from the Fondation de France

06/04/2022

Share this article :

RaphaĆ«l Margueron, head of the Mechanisms of Repression by Polycomb Group Proteins team at Institut Curieā€™s Research Center, is awarded the prize for his work on chromatin defects related to cancer.

I’ve been at Institut Curie for 10 years and I work on the Polycomb proteins that control cell identity,

explained Raphaël Margueron at the Junior Researcher Grand Prix ceremony at the Fondation de France’s medical research gala.

These proteins mark the genes to indicate whether or not they must be expressed. When these proteins are deficient, we see a loss of cell identity. This malfunction has been observed in certain pathologies, including cancer

 

The funding of 50,000 euros attached to this award will allow Margueron’s team - Mechanisms of Repression by Polycomb Group Proteins - to continue its basic research on a gene updated in the gametes, and involved in fertility, but which is also connected to the process of carcinogenesis in a brain cancer sub-type.

In the Genetics and Developmental Biology unit (CNRS UMR3215/Inserm U934/Sorbonne University) at Institut Curie’s Research Center, the team demonstrated the role of Polycomb proteins in epigenetic memory, and observed their deregulation in a certain number of cancers.

 

Research News

New data on the prognosis of different molecular subtypes of bladder cancer

Research

New data on the prognosis of different molecular subtypes of bladder cancer

A team from Institut Curie (CNRS UMR144 / Sorbonne UniversitƩ), led by Prof. Yves Allory and Drs. Isabelle Bernard-Pierrot and FranƧois Radvanyi, has recently shown that outcome after treatment with neoadjuvant chemotherapy differs according to molecular tumor subtype in patients with bladder cancers. These new data, published on September 17, 2024...

10/10/2024